Greater need for treatment optimization in patients with epilepsy initiating adjunctive therapy: Results of a retrospective claims analysis of antiseizure medication drug load in the United States

CONCLUSION: Concomitant ASM drug load increased prior to addition of new ASM, with higher increases observed among patients starting branded vs unbranded ASMs, followed by slight decreases thereafter. Total drug load increased linearly among all patients. These findings underscore the need for ongoing ASM regimen evaluation and treatment optimization in patients with epilepsy.PMID:38277849 | DOI:10.1016/j.yebeh.2024.109649

Source: Epilepsy and Behaviour - January 26, 2024 Category: Neurology Authors: Gregory S Connor David M Labiner Vernon F Schabert Mindl Weingarten Clarence T Wade Sean Stern Danielle A Becker Source Type: research